RA Capital Management’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $122M | Hold |
4,178,823
| – | – | 2.06% | 13 |
|
|
2025
Q1 | $107M | Hold |
4,178,823
| – | – | 1.79% | 13 |
|
|
2024
Q4 | $121M | Hold |
4,178,823
| – | – | 1.61% | 16 |
|
|
2024
Q3 | $99.2M | Hold |
4,178,823
| – | – | 1.14% | 26 |
|
|
2024
Q2 | $72.3M | Hold |
4,178,823
| – | – | 0.96% | 30 |
|
|
2024
Q1 | $93.3M | Buy |
+4,178,823
| New | +$93.3M | 1.19% | 25 |
|
|
2022
Q2 | – | Sell |
-385,481
| Closed | -$13.8M | – | 101 |
|
|
2022
Q1 | $13.8M | Hold |
385,481
| – | – | 0.3% | 68 |
|
|
2021
Q4 | $33.5M | Hold |
385,481
| – | – | 0.59% | 50 |
|
|
2021
Q3 | $44.2M | Hold |
385,481
| – | – | 0.61% | 42 |
|
|
2021
Q2 | $82.9M | Buy |
+385,481
| New | +$82.9M | 1.33% | 23 |
|